Anthracycline induced cardiotoxicity in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
ConclusionsWhile even transient reduction in systolic function may compromise survival outcome, diastolic dysfunction predicts improved survival in patients with AML undergoing HSCT.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Cardiology | Heart | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants